CSIMarket
 
Poseida Therapeutics Inc   (NASDAQ: PSTX)
 

Poseida Therapeutics Inc's Customers Performance

PSTX



 
PSTX's Source of Revenues During the corresponding time, Poseida Therapeutics Inc recorded a revenue increase by 667.19 % year on year, sequentially revenue grew by 176.24 %. While revenue at the Poseida Therapeutics Inc 's corporate clients

List of PSTX Customers




for the same period Poseida Therapeutics Inc recorded revenue increase by 667.19 % year on year, sequentially revenue grew by 176.24 %.

List of PSTX Customers

Poseida Therapeutics Inc's Business Units






Poseida Therapeutics Inc's Comment on Sales, Marketing and Customers



The company serves customers who bill federal programs for products, including healthcare benefit programs such as private third-party payors, Medicaid, and other state programs. It addresses concerns related to the marketing of products for unapproved, off-label uses that are generally non-reimbursable. Products sold in foreign countries may be subject to similar regulatory laws. The company also interacts with healthcare providers, healthcare clearinghouses, health plans (covered entities), and their business associates, all of whom handle individually identifiable health information under HIPAA and HITECH regulations. Additionally, pharmaceutical manufacturers report pricing metrics to the government.





Poseida Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company serves customers who bill federal programs for products, including healthcare benefit programs such as private third-party payors, Medicaid, and other state programs. It addresses concerns related to the marketing of products for unapproved, off-label uses that are generally non-reimbursable. Products sold in foreign countries may be subject to similar regulatory laws. The company also interacts with healthcare providers, healthcare clearinghouses, health plans (covered entities), and their business associates, all of whom handle individually identifiable health information under HIPAA and HITECH regulations. Additionally, pharmaceutical manufacturers report pricing metrics to the government.








PSTX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Poseida Therapeutics Inc 933.09 150.86 -60.76 330
SUBTOTAL 0.00 0.00 0.00 -

Sources: Poseida Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Poseida Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Poseida Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.